Moderna shares continue to rally following a new supply agreement and ahead of the company's upcoming quarterly earnings report.
The main catalyst behind Moderna's recent gains was the European Commission's decision to sign a framework agreement for the supply of up to 24 million doses of the mRESVIA RSV vaccine. The contract, which spans up to four years, opens a new commercial market for Moderna beyond its COVID-19 portfolio and was viewed positively by investors.
The announcement is particularly significant ahead of the company's earnings release. Investors will be watching closely to see whether management incorporates potential mRESVIA deliveries into its updated full-year revenue and commercial sales guidance. Even if official guidance remains unchanged, more optimistic commentary on the vaccine's commercial prospects could provide additional support for the stock.
Moderna needs to break $80 to extend its rally
The previously expected pullback has now fully played out, with MRNA shares correcting after six consecutive days of gains.
The $80 level now represents the key resistance. A decisive breakout above this level would significantly increase the probability of a move toward the recent high at $85.60.
If buyers manage to clear $85.60 while trading volume remains elevated, the next major liquidity zone would be around $92.
The main technical warning signal is RSI (14), which remains in overbought territory. However, during strong trending markets, momentum oscillators often generate premature reversal signals, meaning overbought conditions alone are not enough to confirm a pullback.
Moderna's recovery now hinges on earnings
Despite the strong recovery in Moderna shares, the stock's next major move will largely depend on the upcoming earnings report and management's comments regarding the commercial outlook for mRESVIA and the rest of its product portfolio.
If management delivers a more optimistic outlook for its newer growth drivers, the current uptrend could gain additional momentum.
Latest Moderna News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
